Literature DB >> 35692282

A machine-learning algorithm for distinguishing malignant from benign indeterminate thyroid nodules using ultrasound radiomic features.

Xavier M Keutgen1, Hui Li2, Kelvin Memeh1, Julian Conn Busch1, Jelani Williams1, Li Lan2, David Sarne3, Brendan Finnerty4, Peter Angelos1, Thomas J Fahey4, Maryellen L Giger2.   

Abstract

Background: Ultrasound (US)-guided fine needle aspiration (FNA) cytology is the gold standard for the evaluation of thyroid nodules. However, up to 30% of FNA results are indeterminate, requiring further testing. In this study, we present a machine-learning analysis of indeterminate thyroid nodules on ultrasound with the aim to improve cancer diagnosis.
Methods: Ultrasound images were collected from two institutions and labeled according to their FNA (F) and surgical pathology (S) diagnoses [malignant (M), benign (B), and indeterminate (I)]. Subgroup breakdown (FS) included: 90 BB, 83 IB, 70 MM, and 59 IM thyroid nodules. Margins of thyroid nodules were manually annotated, and computerized radiomic texture analysis was conducted within tumor contours. Initial investigation was conducted using five-fold cross-validation paradigm with a two-class Bayesian artificial neural networks classifier, including stepwise feature selection. Testing was conducted on an independent set and compared with a commercial molecular testing platform. Performance was evaluated using receiver operating characteristic analysis in the task of distinguishing between malignant and benign nodules.
Results: About 1052 ultrasound images from 302 thyroid nodules were used for radiomic feature extraction and analysis. On the training/validation set comprising 263 nodules, five-fold cross-validation yielded area under curves (AUCs) of 0.75 [Standard Error (SE) = 0.04; P < 0.001 ] and 0.67 (SE = 0.05; P = 0.0012 ) for the classification tasks of MM versus BB, and IM versus IB, respectively. On an independent test set of 19 IM/IB cases, the algorithm for distinguishing indeterminate nodules yielded an AUC value of 0.88 (SE = 0.09; P < 0.001 ), which was higher than the AUC of a commercially available molecular testing platform (AUC = 0.81, SE = 0.11; P < 0.005 ).
Conclusion: Machine learning of computer-extracted texture features on gray-scale ultrasound images showed promising results classifying indeterminate thyroid nodules according to their surgical pathology.
© 2022 Society of Photo-Optical Instrumentation Engineers (SPIE).

Entities:  

Keywords:  indeterminate thyroid nodule; machine learning; molecular profiling; radiomics

Year:  2022        PMID: 35692282      PMCID: PMC9133922          DOI: 10.1117/1.JMI.9.3.034501

Source DB:  PubMed          Journal:  J Med Imaging (Bellingham)        ISSN: 2329-4302


  36 in total

1.  Volumetric texture analysis of breast lesions on contrast-enhanced magnetic resonance images.

Authors:  Weijie Chen; Maryellen L Giger; Hui Li; Ulrich Bick; Gillian M Newstead
Journal:  Magn Reson Med       Date:  2007-09       Impact factor: 4.668

Review 2.  Molecular diagnosis for indeterminate thyroid nodules on fine needle aspiration: advances and limitations.

Authors:  Xavier M Keutgen; Filippo Filicori; Thomas J Fahey
Journal:  Expert Rev Mol Diagn       Date:  2013-07       Impact factor: 5.225

3.  Fine needle aspiration biopsy indications for thyroid nodules: compare a point-based risk stratification system with a pattern-based risk stratification system.

Authors:  Jing-Liang Ruan; Hai-Yun Yang; Rong-Bin Liu; Ming Liang; Ping Han; Xiao-Lin Xu; Bao-Ming Luo
Journal:  Eur Radiol       Date:  2019-02-04       Impact factor: 5.315

4.  Radiomics Study of Thyroid Ultrasound for Predicting BRAF Mutation in Papillary Thyroid Carcinoma: Preliminary Results.

Authors:  M-R Kwon; J H Shin; H Park; H Cho; S Y Hahn; K W Park
Journal:  AJNR Am J Neuroradiol       Date:  2020-04       Impact factor: 3.825

5.  Cost-effectiveness of lobectomy versus genetic testing (Afirma®) for indeterminate thyroid nodules: Considering the costs of surveillance.

Authors:  Courtney J Balentine; David J Vanness; David F Schneider
Journal:  Surgery       Date:  2017-11-08       Impact factor: 3.982

6.  Pattern-based vs. score-based guidelines using ultrasound features have different strengths in risk stratification of thyroid nodules.

Authors:  Jung Hyun Yoon; Hye Sun Lee; Eun-Kyung Kim; Hee Jung Moon; Vivian Youngjean Park; Jin Young Kwak
Journal:  Eur Radiol       Date:  2020-02-22       Impact factor: 5.315

7.  Health-Related Quality of Life After Diagnosis and Treatment of Differentiated Thyroid Cancer and Association With Type of Surgical Treatment.

Authors:  Brooke Nickel; Tessa Tan; Erin Cvejic; Peter Baade; Donald S A McLeod; Nirmala Pandeya; Philippa Youl; Kirsten McCaffery; Susan Jordan
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-03-01       Impact factor: 6.223

8.  Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.

Authors:  Nicole A Cipriani; Alexander T Pearson; James M Dolezal; Anna Trzcinska; Chih-Yi Liao; Sara Kochanny; Elizabeth Blair; Nishant Agrawal; Xavier M Keutgen; Peter Angelos
Journal:  Mod Pathol       Date:  2020-12-10       Impact factor: 7.842

9.  Artificial Intelligence in Cytopathology: A Neural Network to Identify Papillary Carcinoma on Thyroid Fine-Needle Aspiration Cytology Smears.

Authors:  Parikshit Sanyal; Tanushri Mukherjee; Sanghita Barui; Avinash Das; Prabaha Gangopadhyay
Journal:  J Pathol Inform       Date:  2018-12-03

10.  Multiplatform molecular test performance in indeterminate thyroid nodules.

Authors:  Mark A Lupo; Ann E Walts; J Woody Sistrunk; Thomas J Giordano; Peter M Sadow; Nicole Massoll; Ryan Campbell; Sara A Jackson; Nicole Toney; Christina M Narick; Gyanendra Kumar; Alidad Mireskandari; Sydney D Finkelstein; Shikha Bose
Journal:  Diagn Cytopathol       Date:  2020-08-07       Impact factor: 1.582

View more
  1 in total

1.  Hypertension and Obesity: Risk Factors for Thyroid Disease.

Authors:  Feng Liu; Xinyu Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-18       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.